ASO Visual Abstract: Neoadjuvant Chemotherapy Does Not Improve Survival in cT2N0M0 Gastric Adenocarcinoma Patients-A Multicenter Propensity Score Analysis

被引:0
|
作者
Abboretti, Francesco [1 ,2 ]
Lambert, Celine [3 ]
Schaefer, Markus [1 ,2 ]
Pereira, Bruno [3 ]
Le Roy, Bertrand [4 ]
Mege, Diane [5 ]
Piessen, Guillaume [6 ,7 ]
Gagniere, Johan [8 ,9 ]
Gronnier, Caroline [10 ,11 ]
Mantziari, Styliani [1 ,2 ]
机构
[1] CHU Vaudois, Lausanne Univ Hosp, Dept Visceral Surg, Lausanne, Switzerland
[2] Univ Lausanne UNIL, Fac Biol & Med, Lausanne, Switzerland
[3] CHU Clermont Ferrand, Biostat Unit, DRCI, Clermont Ferrand, France
[4] CHU St Etienne, Hosp Nord, Dept Digest & Oncol Surg, St Priest En Jarez, France
[5] Aix Marseille Univ, Timone Univ Hosp, APHM, Dept Digest Surg, Marseille, France
[6] CHU Lille, Dept Digest & Oncol Surg, Lille, France
[7] Univ Lille, CHU Lille, Canc Heterogene Plast & Resistance Therapies, CNRS,Inserm,UMR9020,U1277,CANTHER, Lille, France
[8] Estaing Univ Hosp, Dept Digest Surg & Liver Transplantat, Clermont Ferrand, France
[9] Clermont Auvergne Univ, Inserm, U1071, Clermont Ferrand, France
[10] Bordeaux Univ Hosp, Magellan Ctr, Dept Digest Surg, Eso Gastr Surg Unit, Pessac, France
[11] Bordeaux Segalen Univ, Fac Med, Bordeaux, France
关键词
D O I
10.1245/s10434-024-15533-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:8193 / 8194
页数:2
相关论文
共 50 条
  • [1] Neoadjuvant Chemotherapy Does Not Improve Survival in cT2N0M0 Gastric Adenocarcinoma Patients: A Multicenter Propensity Score Analysis
    Abboretti, Francesco
    Lambert, Celine
    Schafer, Markus
    Pereira, Bruno
    Le Roy, Bertrand
    Mege, Diane
    Piessen, Guillaume
    Gagniere, Johan
    Gronnier, Caroline
    Mantziari, Styliani
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 5273 - 5282
  • [2] ASO Visual Abstract: The Effect of Neoadjuvant Therapy on Esophagectomy for cT2N0M0 Esophageal Adenocarcinoma
    Rodriguez-Quintero, Jorge Humberto
    Kamel, Mohamed K.
    Jindani, Rajika
    Elbahrawy, Mostafa
    Vimolratana, Marc
    Chudgar, Neel
    Stiles, Brendon
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (03) : 1595 - 1596
  • [3] Neoadjuvant chemotherapy offers no survival benefit for cT2N0M0 gastric adenocarcinoma. A multicentric European study
    Abboretti, F.
    Lambert, C.
    Schafer, M.
    Le Roy, B.
    Mege, D.
    Demartines, N.
    Pezet, D.
    Gronnier, C.
    Mantziari
    SWISS MEDICAL WEEKLY, 2021, 151 : 14 - 14
  • [4] ASO Author Reflections: Neoadjuvant Chemotherapy in cT2N0M0 Gastric Cancer; Time to Revisit Current Recommendations?
    Abboretti, Francesco
    Schaefer, Markus
    Gronnier, Caroline
    Mantziari, Styliani
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (09) : 6038 - 6039
  • [5] The Effect of Neoadjuvant Therapy on Esophagectomy for cT2N0M0 Esophageal Adenocarcinoma
    Rodriguez-Quintero, Jorge Humberto
    Kamel, Mohamed K.
    Jindani, Rajika
    Elbahrawy, Mostafa
    Vimolratana, Marc
    Chudgar, Neel P.
    Stiles, Brendon M.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : 228 - 238
  • [6] The Effect of Neoadjuvant Therapy on Esophagectomy for cT2N0M0 Esophageal Adenocarcinoma
    Jorge Humberto Rodriguez-Quintero
    Mohamed K. Kamel
    Rajika Jindani
    Mostafa Elbahrawy
    Marc Vimolratana
    Neel P. Chudgar
    Brendon M. Stiles
    Annals of Surgical Oncology, 2024, 31 : 228 - 238
  • [7] ASO Author Reflections: The Road Ahead for cT2N0M0 Esophageal Adenocarcinoma
    Rodriguez-Quintero, Jorge Humberto
    Stiles, Brendon M.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (02) : 892 - 893
  • [8] ASO Author Reflections: The Road Ahead for cT2N0M0 Esophageal Adenocarcinoma
    Jorge Humberto Rodriguez-Quintero
    Brendon M. Stiles
    Annals of Surgical Oncology, 2024, 31 : 892 - 893
  • [9] Does neoadjuvant/perioperative chemotherapy improve overall survival for T2N0 gastric adenocarcinoma?
    Gabriel, Emmanuel
    Attwood, Kristopher
    Narayanan, Sumana
    Brady, Maureen
    Nurkin, Steven
    Hochwald, Steven
    Kukar, Moshim
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (04) : 659 - 670
  • [10] Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer
    Hermans, T. J. N.
    Voskuilen, C. S.
    Deelen, M.
    Mertens, L. S.
    Horenblas, S.
    Meijer, R. P.
    Boormans, J. L.
    Aben, K. K.
    van der Heijden, M. S.
    Pos, F. J.
    de Wit, R.
    Beerepoot, L. V.
    Verhoeven, R. H. A.
    van Rhijn, B. W. G.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (06) : 1453 - 1459